Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

1.66
BATS BZX Real-Time Price
As of 2:29pm ET
 -0.07 / -4.05%
Today’s Change
1.46
Today|||52-Week Range
4.11
-38.97%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close1.73
Today’s open1.75
Day’s range1.65 - 1.75
Volume224,909
Average volume (3 months)710,977
Market cap$156.3M
Dividend yield--
Data as of 2:14pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+3.70%
Earnings growth (this year)+1.28%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.88%
P/E ratioNM
Price/Sales12,577.60
Price/Book8.57

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...-0.02-1.20%
KMDAKamada Ltd-0.04-1.03%
ENZYEnzymotec Ltd-0.08-1.03%
PSTIPluristem Therapeuti...+0.01+0.42%
Data as of 2:29pm ET, 07/29/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$18.8K
Annual profit (last year)-$22.6M
Net profit margin-120,154.75%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientific Officer
Karl Y. Johe
President, CEO, Director &
Legal Counsel
I. Richard Garr
Corporate headquarters
Germantown, Maryland

Forecasts